Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol followed by metoprolol in acute myocardial infarction
ChiCTR2000038206Phase 4Recruiting
- Sponsor
- Pingdingshan First People's Hospital
- Start
- Oct 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esmolol and metoprolol in myocardial infarction (MI) (2 arms), sponsored by Pingdingshan First People's Hospital. Primary endpoints: Incidence of major adverse cardiovascular events and All-cause mortality. Started Oct 2020; status: recruiting.
02
Drugs
esmololmetoprolol
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2000038206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038206.